Alterity Therapeutics (ATH) Short Interest
Alterity Therapeutics (ASX:ATH) had 0.10% of shares reported as short positions as of 24 Aug 2026, representing 214,036 shares. Alterity Therapeutics operates in the Pharmaceuticals, Biotechnology & Life Sciences industry. Source: ASIC short position report (T+4 delay).
Source: official ASIC short position report, T+4 delay. Methodology · Disclaimer — not financial advice.
Alterity Therapeutics
Alterity Therapeutics Limited focuses on developing therapies to treat neurodegenerative diseases associated with aging, like Alzheimer's and Parkinson's disease. The company leverages a novel drug development platform aimed at targeting misfolded proteins. Positioned as a pioneer in this field, Alterity aims to address significant unmet needs in the neurosciences market.
Short position
Alterity Therapeutics (ASX:ATH) has 0.10% of its shares on issue reported as short positions as of 24 Aug 2026, or about 214,036 shares. Over the past 30 days that figure has risen 0.10 percentage points, and over 90 days it has been broadly flat. Its highest recorded short interest was 0.94% in May 2021. ATH is classified in the Pharmaceuticals, Biotechnology & Life Sciences industry. All figures come from official ASIC short position reports, published with a four trading-day (T+4) delay.
Weekly context: The 10 most shorted ASX stocks — Week 35, 2026.
Price & short interest
Toggle series, zoom, and compare · ASIC daily, T+4ATH intelligence dossier
Public-source evidence for this company, with industry drill-up links.
- Tax paid and taxable income records
- Government contracts and public money
- Emissions and trade exposure
- Political donations and lobbying links
Short interest history & FAQ
Company
AI-generated research profile of Alterity Therapeutics
Latest ATH news
All news- Sandfire Resources Shares Hit New ATH Today, Up 27% on Month: The Latest - thebull.com.au
googlenews
- Long Shortz with Alterity Therapeutics: New US patent extends ATH434’s commercial runway
stockhead
- Fisher & Paykel Healthcare Shares Hit New ATH. What Now? - thebull.com.au
googlenews
- Application for quotation of securities - ATH
asx
- Disclosure Under Takeovers Panel GN 20
asx
About
website
address
More Pharmaceuticals, Biotechnology & Life Sciences Stocks
Other shorted stocks in this sector
Be the first to discuss ATH
Start a research thread or post the first pulse update